<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Two patients with <z:hpo ids='HP_0004820'>acute myelomonocytic leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-M4) and a specific chromosomal translocation t(6;9)(p23;q34) are reported and compared to 21 AML patients with the same translocation collected from the literature </plain></SENT>
<SENT sid="1" pm="."><plain>Our observation suggest that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> with t(6;9)(p23;q34) is characterized by <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo>, basophilia, and a variety of blast cell <z:mp ids='MP_0000002'>morphologies</z:mp> (M1, M2, M4) with a greater proportion of the cases than previously appreciated being examples of <z:hpo ids='HP_0004820'>acute myelomonocytic leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-M4) </plain></SENT>
<SENT sid="2" pm="."><plain>The consistent association of <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> provokes the proposal that this subtype of de novo <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> is a result of an <z:hpo ids='HP_0011009'>acute</z:hpo> stem cell disorder </plain></SENT>
<SENT sid="3" pm="."><plain>The poor outcome with standard <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> chemotherapy experienced in this group of relatively young patients necessitates consideration of alternative therapeutic strategies such as early bone marrow transplantation </plain></SENT>
</text></document>